Literature DB >> 21498116

FKBP51 regulation of AKT/protein kinase B phosphorylation.

Liewei Wang1.   

Abstract

FK506 binding protein 51 (FKBP51, also called FKBP5) belongs to a family of immunophilins, FK506 binding proteins (FKBPs). FKBP family members are targets for drugs such as rapamycin. Although FKBP51 shares characteristics with other FKBPs, it also has unique features, especially the role in its regulation of important signaling pathways such as the AKT kinase/protein kinase B pathway. In this review, we will focus on the function of FKBP51 as a scaffolding protein in the regulation of AKT activation and, in turn, its role in tumorigenesis and response to chemotherapy.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21498116      PMCID: PMC3156254          DOI: 10.1016/j.coph.2011.03.008

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  36 in total

1.  Another role for the celebrity: Akt and insulin resistance.

Authors:  Rong Tian
Journal:  Circ Res       Date:  2005-02-04       Impact factor: 17.367

2.  Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex.

Authors:  D D Sarbassov; David A Guertin; Siraj M Ali; David M Sabatini
Journal:  Science       Date:  2005-02-18       Impact factor: 47.728

3.  FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition.

Authors:  G Baughman; G J Wiederrecht; N F Campbell; M M Martin; S Bourgeois
Journal:  Mol Cell Biol       Date:  1995-08       Impact factor: 4.272

4.  PHLPP: a phosphatase that directly dephosphorylates Akt, promotes apoptosis, and suppresses tumor growth.

Authors:  Tianyan Gao; Frank Furnari; Alexandra C Newton
Journal:  Mol Cell       Date:  2005-04-01       Impact factor: 17.970

5.  Crystal structure of an activated Akt/protein kinase B ternary complex with GSK3-peptide and AMP-PNP.

Authors:  Jing Yang; Peter Cron; Valerie M Good; Vivienne Thompson; Brian A Hemmings; David Barford
Journal:  Nat Struct Biol       Date:  2002-12

6.  Transferred nuclear Overhauser effect analyses of membrane-bound enkephalin analogues by 1H nuclear magnetic resonance: correlation between activities and membrane-bound conformations.

Authors:  A Milon; T Miyazawa; T Higashijima
Journal:  Biochemistry       Date:  1990-01-09       Impact factor: 3.162

7.  Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase Balpha.

Authors:  D R Alessi; S R James; C P Downes; A B Holmes; P R Gaffney; C B Reese; P Cohen
Journal:  Curr Biol       Date:  1997-04-01       Impact factor: 10.834

8.  Structure of the large FK506-binding protein FKBP51, an Hsp90-binding protein and a component of steroid receptor complexes.

Authors:  Cindy R Sinars; Joyce Cheung-Flynn; Ronald A Rimerman; Jonathan G Scammell; David F Smith; Jon Clardy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-21       Impact factor: 11.205

9.  Isolation of transforming murine leukemia viruses from mice with a high incidence of spontaneous lymphoma.

Authors:  S P Staal; J W Hartley; W P Rowe
Journal:  Proc Natl Acad Sci U S A       Date:  1977-07       Impact factor: 11.205

10.  Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.

Authors:  Liang Li; Brooke Fridley; Krishna Kalari; Gregory Jenkins; Anthony Batzler; Stephanie Safgren; Michelle Hildebrandt; Matthew Ames; Daniel Schaid; Liewei Wang
Journal:  Cancer Res       Date:  2008-09-01       Impact factor: 12.701

View more
  15 in total

Review 1.  Microbial peptidyl-prolyl cis/trans isomerases (PPIases): virulence factors and potential alternative drug targets.

Authors:  Can M Ünal; Michael Steinert
Journal:  Microbiol Mol Biol Rev       Date:  2014-09       Impact factor: 11.056

2.  Primate-specific melanoma antigen-A11 regulates isoform-specific human progesterone receptor-B transactivation.

Authors:  Shifeng Su; Amanda J Blackwelder; Gail Grossman; John T Minges; Lingwen Yuan; Steven L Young; Elizabeth M Wilson
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

Review 3.  Pharmacogenomics and patient care: one size does not fit all.

Authors:  Kathleen M Giacomini; Sook Wah Yee; Mark J Ratain; Richard M Weinshilboum; Naoyuki Kamatani; Yusuke Nakamura
Journal:  Sci Transl Med       Date:  2012-09-26       Impact factor: 17.956

4.  Increased cortical expression of FK506 binding protein-51 in HIV-associated neurocognitive disorders.

Authors:  Virawudh Soontornniyomkij; Ian P Everall; David J Moore; Ben Gouaux; Erick T Tatro; Vadim Gospodarev; Eliezer Masliah; Nicole S Yin; Harry V Vinters; Cristian L Achim
Journal:  J Neurovirol       Date:  2012-01-11       Impact factor: 2.643

5.  The cyclin D1-CDK4 oncogenic interactome enables identification of potential novel oncogenes and clinical prognosis.

Authors:  Siwanon Jirawatnotai; Samanta Sharma; Wojciech Michowski; Bhoom Suktitipat; Yan Geng; John Quackenbush; Joshua E Elias; Steven P Gygi; Yaoyu E Wang; Piotr Sicinski
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

6.  Mitochondria-nucleus shuttling FK506-binding protein 51 interacts with TRAF proteins and facilitates the RIG-I-like receptor-mediated expression of type I IFN.

Authors:  Taishin Akiyama; Takuma Shiraishi; Junwen Qin; Hiroyasu Konno; Nobuko Akiyama; Miho Shinzawa; Maki Miyauchi; Nobukazu Takizawa; Hiromi Yanai; Hiroyuki Ohashi; Etsuko Miyamoto-Sato; Hiroshi Yanagawa; Weidong Yong; Weinian Shou; Jun-Ichiro Inoue
Journal:  PLoS One       Date:  2014-05-01       Impact factor: 3.240

7.  Transcriptomic profiling of taxol-resistant ovarian cancer cells identifies FKBP5 and the androgen receptor as critical markers of chemotherapeutic response.

Authors:  Nian-Kang Sun; Shang-Lang Huang; Pu-Yuan Chang; Hsing-Pang Lu; Chuck C-K Chao
Journal:  Oncotarget       Date:  2014-12-15

Review 8.  Nuclear PI3K signaling in cell growth and tumorigenesis.

Authors:  William J Davis; Peter Z Lehmann; Weimin Li
Journal:  Front Cell Dev Biol       Date:  2015-04-13

Review 9.  The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease.

Authors:  Gabriel R Fries; Nils C Gassen; Theo Rein
Journal:  Int J Mol Sci       Date:  2017-12-05       Impact factor: 5.923

10.  FKBP51 decreases cell proliferation and increases progestin sensitivity of human endometrial adenocarcinomas by inhibiting Akt.

Authors:  Jing Dong; Yulian Jiao; Wenli Mu; Bingru Lu; Muyun Wei; Linying Sun; Shengnan Hu; Bin Cui; Xiaowen Liu; Zijiang Chen; Yueran Zhao
Journal:  Oncotarget       Date:  2017-06-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.